期刊文献+

宫颈癌演变过程中PTEN、survivin基因的表达及其意义 被引量:6

Expressions of PTEN and survivin in the development of cervical cancer and their clinical significances
下载PDF
导出
摘要 应用qRT-PCR及Western blot技术检测不同阶段宫颈病变组织中PTEN和survivin的表达状况,探讨其临床意义。结果表明:①PTEN mRNA在宫颈癌、CINⅢ组织中的表达显著低于正常宫颈组织(P<0.01),在CINⅡ及CINⅠ组织中的表达亦低于正常宫颈组织(P<0.05);survivin mRNA在宫颈癌、CINⅢ组织中的表达显著高于正常宫颈组织(P<0.01),在CINⅡ组织中的表达亦高于正常宫颈组织(P<0.05),而CIN I组织中则与正常宫颈无差异(P>0.05)。②PTEN蛋白在宫颈癌、CINⅢ、CINⅡ、CIN I组织中显著低于正常宫颈组织(P<0.01),并随着病变程度的增加而减弱。survivin蛋白在宫颈癌、CINⅢ组织中显著高于正常宫颈组织(P<0.01),在CINⅡ中的表达高于正常宫颈组织(P<0.05),而在CINⅠ组织中则与正常宫颈无差异(P>0.05)。说明PTEN和survivin基因在宫颈从癌前病变向宫颈癌演变过程中发挥重要作用,有望成为宫颈癌分子诊断与分子靶向治疗的新靶点。 The expression of PTEN and survivin in the development of uterine cervical cancer were detected by qRTPCR and Western blot techniques.The results were as follows;(1) The expression of PTEN mRNA in cervical cancer and CIN Ⅲ were significantly higher than that in normal cervical epithelium(P〈0.01).The expression of PTEN mRNA in CIN Ⅱ and CIN I were higher than that in normal cervical epithelium(P〈0.05).The expression of survivin mRNA in cervical cancer and CIN Ⅲ were significantly higher than that in normal cervical epithelium(P〈0.01).The expression of survivin mRNA in CIN Ⅱ was higher than that in normal cervical epithelium(P〈0.05).(2) The expression of PTEN in cervical cancer,CIN Ⅲ,CIN Ⅱ and CIN I were significantly higher than that in normal cervical epithelium(P〈0.01),and progressively decreased with the development of cervical epithelial lesions.The expression of survivin in cervical cancer and CIN Ⅲ were significantly higher than that in normal cervical epithelium(P〈0.01).The expression of survivin in CIN Ⅱ was higher than that in normal cervical epithelium(P〈0.05).These results suggested that PTEN and survivin might play an important role in the progression from CIN to the cervical cancer.PTEN and survivin would be promising biomarkers for potential molecular diagnosis and therapeutic targets of the cervical cancer.
出处 《扬州大学学报(农业与生命科学版)》 CAS CSCD 北大核心 2014年第4期10-13,共4页 Journal of Yangzhou University:Agricultural and Life Science Edition
基金 江苏省高校研究生科技创新计划项目(CXZZ13-0918)
关键词 PTEN SURVIVIN 宫颈上皮内瘤样病变 宫颈鳞状上皮细胞癌 生物学标志物 PTEN survivin cervical intraepithelial neoplasia cervical squamous cell carcinomas biomarkers
  • 相关文献

参考文献12

  • 1Jemal A, Bray F, Center M M, et al. Global cancer statistics [J]. CA Cancer J Clin, 2011, 61:69 90.
  • 2Zur H H. Papillomaviruses in the causation of human cancers a brief historical account [J]. Virology, 2009, 384: 260-265.
  • 3Leslie N R, den Hertog J. Mutant PTEN in cancer., worse than nothing [J]. Cell, 2014, 157(3): 527-529.
  • 4Groner B, Weiss A. Targeting survivin in cancer., novel drug development approaches [J]. Bio Drugs, 2014, 28(1) : 27-39.
  • 5Vazquez-Mena O, Medina-Martinez I, Judrez-Torres E, et al. Amplified genes may be overexpressed, unchanged, or downregulated in cervical cancer cell lines [J]. PLoS One, 2012, 7(3) : e32667.
  • 6Kitchener H C, Hoskins W, Small W J, et al. The development of priority cervical cancer trials: a gynecologic cancer inter group report[J]. Int J Gynecol Cancer, 2010, 20(6) : 1092-1100.
  • 7Ojesina A I, Lichtenstein L, Freeman S S, et al. Landscape of genomic alterations in cervical carcinomas [J]. Na- ture, 2014, 506(7488): 371-375.
  • 8Baker S J. PTEN enters the nuclear age [J]. Cell, 2007, 128(1) : 25-28.
  • 9Vazquez-Ulloa E, Lizano M, Aviles-Salas A, et al. Abnormal distribution of hDlg and PTEN in premalignant le- sions and invasive cervical cancer [J]. Gynecol Oncol, 2011, 122(3): 663-668.
  • 10Zaffaroni N, Costa A, Pennati M, et al. Survivin is highly expressed and promotes cell survival in malignant peri- toneal mesothelioma [J]. Cell Oneol, 2007, 29(6) : 453-466.

二级参考文献14

  • 1郎景和.子宫内膜异位症研究的新里程[J].中华妇产科杂志,2005,40(1):3-4. 被引量:280
  • 2孔祥,肖蔚,陈刚,王志学.核转录因子在卵巢癌组织及细胞系的表达和意义[J].扬州大学学报(农业与生命科学版),2004,25(4):75-77. 被引量:6
  • 3Matarese G, De Placido G, Nikas Y, et al. Pathogenesis of endometriosis: natural immunity dysfunction or autoim- munedisease[J]. Trends MolMed, 2003, 9(5): 223-228.
  • 4Sakamoto Y, Harada T, Horie S, et al. Tumor necrosis factor-alpha induced interleukin-8 (IL-8) expression in en- dometriotic stromal cells, probably through nuclear factor-kappa B activation., gonadotropin releasing hormone ago- nist treatment reduced IL-8 expression [J]. Clin Endocrinol Metab, 2003, 88(2): 730-735.
  • 5Lebovic D I, Chao V A, Martini J F, et al. IL-1 beta induction of RANTES (regulated upon activation, normal T cell expressed and secreted) chemokine gene expression in endometriotic stromal cells depends on a nuclear factor- kappaB site in the proximal promoter [J]. Clin Endocrinol Metab, 2001, 86(10): 4759-4764.
  • 6Lin W, Chen S, Li M, et al. Expression of macrophage migration inhibitory factor in human endometriosis: rela- tion to disease sta~e, menstrual evcle and infertility[J]. I Obstet Gvnaeeol Res, 2010, 36(2):344-361.
  • 7May K E, Conduit-Hulbert S A, Kirtley J, et al. Peripheral biomarkers of endometriosis: a systematic review[J]. Hum Reprod Update, 2010, 16: 651-674.
  • 8Bruner-Tran K L, Rier S E, Eisenberg E, et al. The protein role of environmental toxins in the pathophysiology of endometriosis [J]. Gvnecol Obstet Invest, 1999, 48(1): 45-46.
  • 9Sherwin J R A, Hastings J M, Jackson K S, et al. The endometrial response to chorionic gonadotropin is blunted in a baboon model of endometriosis [J]. Endocrinology, 2010, 151: 4982-4993.
  • 10Onodera S, Sasaki S, Ohshima S, et al. Transgenic mice overexpressing macrophage migration inhibitory factor (MIF) exhibit high-turnover osteoporosis [J].J Bone Miner Res, 2006, 21(6): 876-885.

共引文献4

同被引文献72

  • 1原继荣,张玲,付小萌,肖兵,杜亚丽.液基细胞学技术、阴道镜及PTEN和p27基因表达对宫颈癌的诊断意义[J].中国现代医学杂志,2006,16(24):3777-3780. 被引量:2
  • 2高慧,黄正芳,潘金春,徐向明,薛整风,李厚达.人乳头瘤病毒16L1蛋白的原核表达及免疫原性研究[J].扬州大学学报(农业与生命科学版),2005,26(1):9-12. 被引量:2
  • 3吴颜晖,陈汉春,刘新发,李新梅,曹燕飞.中国人食管鳞癌10q23微卫星不稳定和杂合性缺失初步探讨[J].中国肿瘤临床,2004,31(8):466-468. 被引量:9
  • 4周琦,叶学正,唐郢,黄海萍,张代奎.PTEN基因在宫颈癌中的表达及与预后的关系[J].肿瘤学杂志,2007,13(2):121-122. 被引量:11
  • 5Ferlay J, Shin H R, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 [J]. lnt J Cancer, 2010, 127(12): 2893-2917.
  • 6Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 V1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [OL]. Lyon, France: International Agency for Research on Cancer, 2013.
  • 7Corfield A P. Mucins: A biologically relevan glycan barrier in mucosal protection [J]. Biochim Biophys Acta, 2014, 1850(1): 236-252.
  • 8Manne U, Weiss H L, Grizzle W E. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorec- tal adenocarcinomas [J]. Clin Cancer Res, 2000, 6(10) : 4017-4025.
  • 9Mukhopadhyay P, Chakraborty S, Ponnusamy M P, et al. Mucins in the pathogenesis of breast cancer: implica- tions in diagnosis, prognosis and therapy [J]. Biochim Biophys Acta, 2011, 1815(2) : 224-240.
  • 10Yamada K, Morinaga Y, Yanagihara K, et al. Azithromycin inhibits MUC5AC induction via multidrug-resistant Acinetobacter baumannii in human airway epithelial cells [J]. Pulm Pharmacol Ther, 2014, 28(2): 165-170.

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部